{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:39:33Z","timestamp":1790995173032,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2022-138461OB-I00"],"award-info":[{"award-number":["PID2022-138461OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021528","name":"Advancing a Healthier Wisconsin Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005910","name":"Albert Ellis Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116879","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T15:16:59Z","timestamp":1717773419000},"page":"116879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance"],"prefix":"10.1016","volume":"176","author":[{"given":"Kelsey G.","family":"Guenther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia J.","family":"Hillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-6199","authenticated-orcid":false,"given":"Ken","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G.","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2024.116879_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.biopha.2024.116879_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40263-022-00924-2","article-title":"Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation","volume":"36","author":"Coluzzi","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2024.116879_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.aat.2014.11.001","article-title":"Attenuation of morphine-induced dependence and tolerance by ceftriaxone and amitriptyline in mice","volume":"52","author":"Habibi-Asl","year":"2014","journal-title":"Acta Anaesthesiol. Taiwan."},{"key":"10.1016\/j.biopha.2024.116879_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pbb.2015.08.002","article-title":"Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin","volume":"137","author":"Mansouri","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2024.116879_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainresbull.2016.07.002","article-title":"Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice","volume":"125","author":"Hassanipour","year":"2016","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.biopha.2024.116879_bib6","first-page":"55","article-title":"Attenuation of morphine tolerance and dependence by thymoquinone in mice","volume":"6","author":"Hosseinzadeh","year":"2016","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.biopha.2024.116879_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coph.2009.09.009","article-title":"Cannabinoid \u2013 opioid interactions during neuropathic pain and analgesia","volume":"10","author":"Bushlin","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116879_bib8","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.3390\/jcm11226675","article-title":"A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis\u2014Clinical Implications","volume":"11","author":"Wo\u0142yniak","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2024.116879_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0953-816X.2004.03177.x","article-title":"Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain","volume":"19","author":"Finn","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116879_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.neuropharm.2009.08.005","article-title":"Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.","volume":"58","author":"Fischer","year":"2010","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.biopha.2024.116879_bib11","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/bph.13534","article-title":"Opioid and cannabinoid synergy in a mouse neuropathic pain model","volume":"173","author":"Kazantzis","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116879_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","article-title":"Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside","volume":"6","author":"Rahn","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2024.116879_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09540260902782752","article-title":"Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence","volume":"21","author":"Cooper","year":"2009","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.biopha.2024.116879_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116879_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","article-title":"Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal","volume":"77","author":"Deng","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.biopha.2024.116879_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brainres.2005.08.002","article-title":"Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure","volume":"1059","author":"Lim","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2024.116879_bib17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1476-5381.2012.01948.x","article-title":"Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells","volume":"166","author":"Merighi","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116879_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2013.12.030","article-title":"Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia","volume":"261","author":"Desroches","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2024.116879_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.117.109355","article-title":"Slowly signaling G-protein biased CB2 cannabinoid receptor agonist LY2828360 supresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence","volume":"93","author":"Lin","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116879_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.118.113233","article-title":"Cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal","volume":"96","author":"Li","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116879_bib21","article-title":"Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-reroviral toxic neuropathy.","volume":"187","author":"Carey","year":"2023","journal-title":"Pharma. Res."},{"key":"10.1016\/j.biopha.2024.116879_bib22","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/jm400305d","article-title":"Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain","volume":"56","author":"Hollinshead","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116879_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/j.pain.0000000000002502","article-title":"A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy- induced peripheral neuropathy: evidence from a CB2 reporter mouse","volume":"163","author":"Lin","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.116879_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109601","article-title":"Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain","volume":"237","author":"Guenther","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2024.116879_bib25","first-page":"S56","article-title":"A proof-of concept (poc) study including experimental pain models (epms) to assess the effecrs of a CB2 agonist (LY2828360) in the treatment of patients with osteoarthritic (oa) knee pain","volume":"93","author":"Pereira","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116879_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pbb.2011.02.024","article-title":"Pharmacological characterization of AM1710, a putative cannabinoid CB2agonist from the cannabilactone class: antinociception without central nervous system side-effects","volume":"98","author":"Rahn","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2024.116879_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-018-1174-9","article-title":"Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer\u2019s disease","volume":"15","author":"L\u00f3pez","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116879_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.116879_bib29","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1073\/pnas.0914725107","article-title":"Deletion of PIK3C3\/Vps34 in sensory neurons causes rapid neurodegeneration by disrupting the endosomal but not the autophagic pathway","volume":"17","author":"Zhou","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2024.116879_bib30","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1073\/pnas.1014411108","article-title":"Proper formation of whisker barrelettes requires periphery-derived Smad4-dependent TGF-\u03b2 signaling","volume":"108","author":"Da Silva","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116879_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real- time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2024.116879_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/15748898112079990016","article-title":"Different classes of CB2 ligands potentially useful in the treatment of pain","volume":"8","author":"Murineddu","year":"2013","journal-title":"Recent Pat. CNS Drug. Discov."},{"key":"10.1016\/j.biopha.2024.116879_bib33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/14728222.2021.1971196","article-title":"The CB2 cannabinoid receptor as a therapeutic target in the central nervous system","volume":"25","author":"Caba\u00f1ero","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2024.116879_bib34","unstructured":"Behlke, C.A., Krause, L., Sterrett, J., Moe, A., Hillard, C.J., 2022. Cell specific roles of the CB2R in the acute locomotor response to cocaine [abstract], 2022 June 25-30. In: 32nd Annual Symposium of the International Cannabinoid Research Society. ICRS, Galway, Ireland. Abstract nr 34."},{"key":"10.1016\/j.biopha.2024.116879_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:51:13Z","timestamp":1781650273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224007637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":35,"alternative-id":["S0753332224007637"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116879","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116879"}}